Unit 4- Blood Flashcards

1
Q

Vein Thrombosis

A

Red thrombi of RBC embedded in fibrin, treat with anticoagulants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Coronary Artery Thrombosis

A

White thrombi of platelets embedded in fibrin, treat with antiplatelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Phases of Hemostasis

A

Vascular spasm where blood vessel is damaged, clotting factors cleave prothrombin into thrombin, platelet plug forms, thrombin IIa cleaves fibrinogen into insoluble fibrin, coagulation occurs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Platelet Pathway

A

NO, prostacyclin, or ADPase activate platelets that produce TXA2 and ADP, activating more platelets, activated platelets aggregate due to clotting factors, fibrin deposits and it becomes a clot

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

The Clotting Cascade

A

Vascular injury releases tissue factor, factor VIIa is produced, factor X is activated, activating factor II prothrombin to factor IIa thrombin, that cleaves fibrinogen into fibrin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Zymogens

A

Precursor proteins, most clotting factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Factor IV

A

Ca++, cofactor for thrombin activation and fibrinogen to fibrin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Blood Coagulation

A

Activation of prothrombin activators, thrombin activation, and fibrin formation, 12 zymogen factors work together

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Antithrombin III

A

AT, inhibits coagulation through fibrinolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Conditions Requiring Anticoagulant

A

Thrombosis, coronary syndrome, arterial fibrillation, stroke, ischemic heart disease, thromboembolic disease in IMHA, antithrombotic prophylaxis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Anticoagulatns

A

Modify the coagulation cascade, heparin and LMWHs, warfarin and coumarin derivatives, thrombin inhibitors, and factor Xa inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Heparin

A

Binds AT and enhances inhibitory effects, inactivating IIa and Xa, found in mast cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Heparin Use

A

Excessive clotting or risk of clotting, thromboembolic disease, venous thrombosis, disseminated intravascular coagulopathy, pulmonary thromboembolism, laminitis, endotoxic shock, burns

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Unfractionated Heparin

A

Inactivates thrombin and factor Xa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Low Molecular Weight Heparin

A

Inactivates factor Xa, dalteparin and enoxaparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Heparin Dosing

A

AT levels affect efficacy, variable PK, activated partial thromboplastin time test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Heparin Adverse Effects

A

Bleeding problems, thrombocytopenia, overdose causes excessive anticoagulation and bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Heparin Overdose Reversal

A

Protamine sulfate binds acidic heparin to create inactive salt

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

LMWH Advantages

A

Greater activity and safety, predictable PK

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Dalteparin

A

LMWH, binds AT to increase AT mediated inhibition of synthesis and activity of factor Xa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Dalteparin Adverse Effects

A

Bleeding, hematoma from IM admin, prolonged elimination from renal disease, drug interactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Enoxaparin

A

LMWH, binds AT to increase AT mediated inhibition of synthesis and activity of factor Xa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Enoxaparin Adverse Effects

A

Bleeding, hematoma from IM, prolonged elimination from renal disease, drug interactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Vitamin K

A

Essential for hepatic synthesis of prothrombin factors II, VII, IX, and X

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Coumarin Derivatives
Anticoagulants, warfarin, dicumarol, acenocoumarol, reduce production of vitamin K dependent factors by inhibiting vitamin K regeneration
26
Coumarin Derivative Uses
Decrease thrombosis tendency in dogs, treat clots in vein or artery, reduce risk of stroke or heart attack
27
Coumarin Derivative Adverse Effects
Decreased blood clotting, spontaneous bleeding, excessive bleeding, drug interactions with aspirin and clopidogrel
28
Vitamin K Deficiency
Excessive bleeding due to failure of fibrin clot formation, poisoning by warfarin, treat with menadione
29
Heparin Characteristics
Accelerates antithrombin activity, immediate onset, short duration, parenteral admin, treat overdose with protamine, test with clotting time
30
Warfarin Characteristics
Inhibits hepatic synthesis of vitamin K dependent clotting factors, delayed onset, long duration, oral admin, treat overdose with vitamin K, test with prothrombin time
31
Factor Xa Inhibitors
Rivaroxaban and apixaban, predictable PK, no monitoring needed, less affected by diet, short half life and unable to be reversed
32
Thrombin Inhibitors
Dabigatran, less drug interaction, reversed with Idarucizumab, can cause bleeding and GI problems
33
Hemophilia
Inherited deficiency of clotting factors, diagnosed by blood test and coagulation time test
34
Hemophilia Treatment
Blood transfusion, cryoprecipitate from blood, factor VIII
35
Hemophilia A
Lack of factor VIII, X linked and common in males, spontaneous bleeding into muscle, joints, or under skin, hemorrhage in chest or abdomen, excessive bleeding after surgery
36
Hemophilia A Diagnosis
During surgery, in young animals with excessive bleeding, bleeding of gums, may be stillborn or die as neonate
37
Factor VIII
Cofactor of factor IX to activate factor X
38
Hemophilia B
Lack of factor IX, milder than hemophilia A, spontaneous bleeding, not noticed until emergency
39
Hemophilia C
Extremely rare factor XI deficiency, bleeding induced by trauma or surgery and can be delayed
40
Von Willibrand Disease
Most common inherited clotting disease, lack of vWB factor important for platelet adhesion
41
Predisposition to Thrombosis
Injury to vessel wall, altered blood flow, abnormal coagulation
42
Arterial Thrombus
Atherosclerosis, can cause ischemia, carotid emboli can cause stroke
43
Venous Thrombus
Forms an embolus, venous emboli can go to pulmonary artery and cause pulmonary embolism
44
Embolism
Thrombus that has traveled far from where it formed
45
Thromboembolic Diseases
Feline cardiomyopathy, pulmonary endarteritis from heartworms, membranous glomerulonephritis, mild disseminated intravascular coagulopathy, pulmonary thromboembolism, vasculitis, laminitis, navicular disease
46
Aspirin
Binds COX-1 preventing TXA2 synthesis that activates platelets, metabolized in liver, cats require less dosage, excreted by kidney
47
Aspirin MOA
Binds platelet COX1 preventing TXA2 formation and preventing vasoconstriction at low doses, binds COX2 preventing prostaglandin production and causing analgesia at high doses
48
Clopidogrel
Prodrug, metabolite blocks platelet aggregation, used with aspirin but preferred in vet med
49
Clopidogrel Adverse Effects
Vomiting, anorexia, diarrhea
50
Clopidogrel MOA
Active metabolite irreversibly binds P2Y12 ADP receptors on platelets, blocking platelet aggregation
51
Ticlopidine
P2Y12 receptor inhibitor, rarely used in animals, causes adverse effects in cats
52
Abciximab
Antibody to anti-glycoprotein IIb/IIIa receptor preventing thrombosis during percutaneous coronary intervention
53
Abciximab MOA
Reversibly binds platelet IIb/IIIa receptor that binds fibrinogen, vWB factor, and other adhesive platelet molecules
54
Fibrinolysis
Antithrombin III breaks down fibrin in blood clots, tPA and factor XIa and XIIa activate plasminogen to plasmin that degrades fibrin
55
Streptokinase
Plasminogen activator, thrombolytic medication, combines with plasminogen to form activator complexes that convert plasminogen to plasmin
56
Streptokinase Therapeutic Effects
Lysis of thrombi in cat heart attack, lysis of pulmonary embolism in dog, deep venous thrombosis in dog
57
Streptokinase Adverse Effects
Systemic fibrinolysis, coagulopathy, serious hemorrhage, metabolic acidosis, bleeding, death
58
Recombinant Tissue Plasminogen Activator
rt-PA, protease with specificity for fibrin within thrombi, causes less systemic bleeding problems, high mortality in cats
59
Antifibrinolytics
Promote hemostasis, aminocaproic acid and tranexamic acid, lysine compounds that bind to fibrin to decrease fibrinolysis
60
Regenerative Anemia
Bone marrow produces normal RBC but blood loss occurs
61
Immune Mediated Hemolytic Anemia
Breakdown of RBC
62
Nonregenerative Anemia
Deficiency of blood cell production
63
Erythropoietin
Produced by kidneys, stimulates RBC production in bone marrow
64
Iron Deficiency Anemia
Hemoglobin contains iron to bind to O2, most common in dogs and piglets after chronic blood loss
65
Sickle Cell Anemia
Mutation in hemoglobin gene causes malformation of subunit, deformity of RBC restricts O2 carrying capacity
66
Oxbryta
Inhibits hemoglobin beta polymerization and RBC sickling
67
Vitamin B12 Anemia
Cobalamin creates heme portion, deficiency results in low RBC and hematological and neuro problems
68
Ferdex B12
Injectable B12 for treatment of iron deficient anemia
69
Azathioprine
Immune suppressant, decreases purine metabolism, treats IMHA and immune mediated thrombocytopenia
70
Azathioprine Adverse Effects
Bone marrow suppression, CI toxicity, liver toxicity, pancreatitis in dogs
71
Cyclophosphamide
Immunosuppressant with cytotoxic effects on lymphocytes
72
Cyclophosphamide Adverse Effects
Bone marrow suppression and sterile hemorrhagic cystitis in dogs
73
Cyclosporine
Inhibits T cell signal transduction, suppresses IL2, blocks T cell activation, treats IMHA and immune mediated thrombocytopenia
74
Erythropoietin Stimulating Agents
Epoetin alpha and darbepoetin, stimulate erythropoiesis to treat anemia
75
Chronic Non Regenerative Anemia
Common in cats, decreased erythropoietin production, treat with darbepoetin